Effects of troglitazone on insulin sensitivity in HIV-infected patients with protease inhibitor-associated diabetes mellitus.
- 1 September 1999
- journal article
- clinical trial
- Published by Springer Nature in Zeitschrift für Die Gesamte Experimentelle Medizin
- Vol. 199 (5) , 253-262
- https://doi.org/10.1007/s004330050123
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophyThe Lancet, 1999
- Insulin Resistance SyndromeSouthern Medical Journal, 1999
- Efficacy and Metabolic Effects of Metformin and Troglitazone in Type II Diabetes MellitusNew England Journal of Medicine, 1998
- Effect of Troglitazone in Insulin-Treated Patients with Type II Diabetes MellitusNew England Journal of Medicine, 1998
- Effects of troglitazone and metformin on glucose and lipid metabolismBiochemical Pharmacology, 1997
- Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patientsDiabetologia, 1996
- Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS)European Journal of Clinical Investigation, 1994
- Validation of the low dose short insulin tolerance test for evaluation of insulin sensitivityClinical Endocrinology, 1994
- Effects of metformin on haemorheology, lipid parameters and insulin resistance in insulin-dependent diabetic patients (IDDM)Biomedicine & Pharmacotherapy, 1991
- Metformin Revisited: Its Actions and Indications for UseDiabetic Medicine, 1988